+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Diagnostics Market - Global Forecast 2025-2030- Product Image
Breast Cancer Diagnostics Market - Global Forecast 2025-2030- Product Image
Sale

Breast Cancer Diagnostics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5206469
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The breast cancer diagnostics market is undergoing dynamic transformation as precision technologies and integrative clinical approaches reshape early detection pathways and improve patient outcomes. Senior decision-makers are challenged to navigate an evolving landscape that blends advanced imaging, molecular profiling, and digital workflows to drive both improved accuracy and operational efficiency.

Market Snapshot: Breast Cancer Diagnostics Market Overview

The breast cancer diagnostics market grew from USD 7.04 billion in 2024 to USD 7.60 billion in 2025. The sector is projected to expand at a CAGR of 7.82%, reaching USD 11.07 billion by 2030. This growth is propelled by increased demand for early detection, advancements in molecular diagnostics, and wider adoption of digital imaging modalities. The market landscape is increasingly driven by regulatory changes, data-driven patient management, and the push for scalable diagnostic solutions in both established and emerging healthcare systems.

Scope & Segmentation

  • Technology: Biopsy (needle and surgical), histopathology (immunohistochemistry, staining systems), imaging (digital breast tomosynthesis, conventional and digital mammography, MRI, ultrasound), and molecular diagnostics (FISH, targeted and whole genome next generation sequencing, PCR-based diagnostics including digital and real-time PCR).
  • Product: Consumables (reagents, kits, slides, staining reagents), instruments (biopsy devices, histopathology equipment, imaging systems, sequencers), software and services (consulting, maintenance, data analysis tools).
  • Biomarker: BRCA mutations, ER/PR status, HER2, Ki-67, and related molecular indicators that drive personalized diagnostics and treatment planning.
  • Sample Type: Blood, serum, and tissue based diagnostic strategies enable flexibility in clinical workflows and access to critical biomarker insights.
  • End User: Cancer research centers, diagnostic laboratories, hospitals, and specialized clinics, each contributing to the market’s adoption dynamics and innovation cycles.
  • Geography: Americas (United States, Canada, Mexico, Brazil, Argentina, and key states in the US), Europe, Middle East & Africa (including major and emerging markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Companies Analyzed: F. Hoffmann-La Roche Ltd., GE HealthCare Technologies GmbH, Siemens Healthineers AG, Hologic, Inc., Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, QIAGEN N.V., Illumina, Inc., Becton, Dickinson and Company.

Key Takeaways: Strategic Insights for Leaders

  • Clinical adoption of integrated imaging and molecular diagnostics supports decision-making at subclinical and early stages, leading to enhanced patient management and reduced diagnostic uncertainty.
  • Artificial intelligence and machine learning algorithms are now a core part of diagnostic radiology and pathology, minimizing false positives and underpinning real-time, data-driven workflows.
  • Regulatory frameworks and streamlined approval processes are enabling more rapid market entry for innovative assays, with industry collaboration driving quality and interoperability across platforms.
  • Reimbursement models and regional funding variations significantly influence the pace of technology integration, particularly in emerging markets where access and infrastructure are evolving.
  • Central and decentralized diagnostic models are advancing simultaneously, enabled by telemedicine, cloud-based analytics, and modular assay platforms, broadening access to underserved areas and supporting global health equity initiatives.
  • Ongoing industry consolidation and strategic partnerships are expanding product portfolios, enabling rapid response to evolving clinical needs and shifting regulatory requirements.

Tariff Impact: Addressing Supply Chain and Cost Challenges

Forthcoming tariff changes in the United States are expected to affect the cost structure of breast cancer diagnostic equipment and consumables. This may drive technology providers to reassess sourcing strategies, implement domestic production, and actively seek regulatory exemptions. Organizations are increasingly diversifying supplier networks and partnering with federal agencies to mitigate disruption, minimize cost impacts, and maintain reliable access to next-generation diagnostic solutions.

Methodology & Data Sources

This analysis integrates direct engagement with clinical practitioners and diagnostics experts, systematic reviews of peer-reviewed literature, quantitative surveys of laboratory adoption, and validation against corporate and regulatory filings. Findings are supported by regionally targeted expenditure and policy reports and synthesized through iterative subject-matter expert workshops to ensure rigor and actionable clarity.

Why This Report Matters

  • Enables decision-makers to track market-defining technology shifts, regulatory updates, and vibrant competitive activity in breast cancer diagnostics.
  • Supports strategic planning with comprehensive segmentation and global trends, helping institutions future-proof investments and clinical operations.
  • Guides risk management and supply chain strategies in response to evolving policy landscapes and technology standards.

Conclusion

The breast cancer diagnostics market is at the forefront of innovation, defined by integrated clinical technologies and adaptive business strategies. Leaders equipped with these insights are positioned to drive operational excellence and sustained impact across organizational and geographic boundaries.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of machine learning algorithms for enhanced lesion detection in digital mammography
5.2. Expansion of circulating tumor DNA liquid biopsy tests for early breast cancer monitoring
5.3. Integration of patient-centric mobile health platforms for treatment adherence tracking
5.4. Regulatory approvals driving companion diagnostics for targeted HER2 and PIK3CA therapies
5.5. Implementation of risk stratification models combining genetics and imaging biomarkers
5.6. Development of 3D automated breast ultrasound systems to improve detection rates in dense tissue
5.7. Emergence of decentralized clinical trials leveraging remote diagnostics and telehealth visits
5.8. Growing payer incentives and reimbursement frameworks for preventive breast cancer screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Biopsy
8.2.1. Needle Biopsy
8.2.2. Surgical Biopsy
8.3. Histopathology
8.3.1. Immunohistochemistry
8.3.2. Staining Systems
8.4. Imaging
8.4.1. Digital Breast Tomosynthesis
8.4.2. Mammography
8.4.3. MRI
8.4.4. Ultrasound
8.5. Molecular Diagnostics
8.5.1. FISH
8.5.2. NGS
8.5.2.1. Targeted NGS
8.5.2.2. Whole Genome Sequencing
8.5.3. PCR-Based
8.5.3.1. Digital PCR
8.5.3.2. Real-Time PCR
9. Breast Cancer Diagnostics Market, by Product
9.1. Introduction
9.2. Consumables
9.2.1. Reagents And Kits
9.2.2. Slides And Staining Reagents
9.3. Instruments
9.3.1. Biopsy Devices
9.3.2. Histopathology Instruments
9.3.3. Imaging Systems
9.3.4. Sequencers
9.4. Software And Services
9.4.1. Consulting And Maintenance
9.4.2. Data Analysis Software
10. Breast Cancer Diagnostics Market, by Biomarker
10.1. Introduction
10.2. BRCA
10.3. ER/PR
10.4. HER2
10.5. Ki-67
11. Breast Cancer Diagnostics Market, by Sample Type
11.1. Introduction
11.2. Blood
11.3. Serum
11.4. Tissue
12. Breast Cancer Diagnostics Market, by End User
12.1. Introduction
12.2. Cancer Research Centers
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Specialized Clinics
13. Americas Breast Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Breast Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Breast Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. GE HealthCare Technologies GmbH
16.3.3. Siemens Healthineers AG
16.3.4. Hologic, Inc.
16.3.5. Koninklijke Philips N.V.
16.3.6. Thermo Fisher Scientific Inc.
16.3.7. Abbott Laboratories
16.3.8. QIAGEN N.V.
16.3.9. Illumina, Inc.
16.3.10. Becton, Dickinson and Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BREAST CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BREAST CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BREAST CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BREAST CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. BREAST CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. BREAST CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. BREAST CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BREAST CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NEEDLE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NEEDLE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STAINING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STAINING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TARGETED NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SLIDES AND STAINING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SLIDES AND STAINING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSULTING AND MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSULTING AND MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BRCA, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER/PR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY ER/PR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER2, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HER2, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KI-67, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY KI-67, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BREAST CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 182. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 183. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 184. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 185. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 186. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 187. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 188. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 189. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 190. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 191. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 192. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 193. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 196. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 197. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 200. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 201. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 202. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 203. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 204. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 205. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. CANADA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 213. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PCR-BASED, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER DIAGNOSTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies GmbH
  • Siemens Healthineers AG
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • QIAGEN N.V.
  • Illumina, Inc.
  • Becton, Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.07 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Next-Generation Breast Cancer Diagnostic & Screening Market - Global Forecast 2025-2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2025-2030 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market Report by Product Services, Circulating Biomarker, End User, and Region 2025-2033 - Product Image

Breast Cancer Liquid Biopsy Market Report by Product Services, Circulating Biomarker, End User, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Breast Cancer Liquid Biopsy - Global Strategic Business Report - Product Image

Breast Cancer Liquid Biopsy - Global Strategic Business Report

  • Report
  • 217 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.